Esperion Therapeutics reported $261.78M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amarin AMRN:US USD 686.52M 32.6M
Amgen AMGN:US USD 24.06B 4.74B
Biogen BIIB:US USD 9.77B 24.9M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Cytokinetics CYTK:US USD 884.28M 282.02M
Daiichi Sankyo 4568:JP JPY 1.46T 90.16B
Eli Lilly And LLY:US USD 17.64B 524.7M
Esperion Therapeutics ESPR:US USD 261.78M 9.31M
Geron GERN:US USD 222.07M 5.3M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Intra Cellular Therapies ITCI:US USD 759.76M 29.45M
Minerva Neurosciences NERV:US USD 44.84M 5.2M
Moderna Inc MRNA:US USD 14.3B 734M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Puma Biotechnology PBYI:US USD 122.35M 8.07M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Seattle Genetics SGEN:US USD 2.76B 19.04M
United Therapeutics UTHR:US USD 3.06B 372.1M
Vanda Pharmaceuticals VNDA:US USD 507.11M 10.21M